Needham & Company Raises Price Target on Faro Technologies (FARO) to $39 Following 2nd Consecutive Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Unusual 11 Mid-Day Movers 5/4: (EBIO) (GKOS) (QUAD) Higher; (FSTR) (DXYN) (CRAY) Lower
May 4, 2016 12:58 PM EDTEleven Biotherapeutics (Nasdaq: EBIO) 34.7% HIGHER; gaining for the second session after the company presented new data from post hoc analyses on the influence of Interleukins IL-1 genetic patterns on response to isunakinra (EBI-005) in severe allergic conjunctivitis and severe dry eye study subjects.
L.B. Foster (Nasdaq: FSTR) 28.2% LOWER; reported Q1 EPS of ($0.28), $0.20 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $126.3 million versus the consensus estimate of $128.9 million.
Glaukos Corporation (NYSE:... More
Faro Technologies (FARO) Tops Q1 EPS by 15c
May 3, 2016 4:40 PM EDTFaro Technologies (NASDAQ: FARO) reported Q1 EPS of $0.19, $0.15 better than the analyst estimate of $0.04. Revenue for the quarter came in at $75.7 million versus the consensus estimate of $71.74 million.
For earnings history and earnings-related data on Faro Technologies (FARO) click here.
... More